SCHEMBL3790255

SCHEMBL3790255

Nc1cc(Oc2ccccc2)cc(-c2ccccc2N)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
NLRP3 Q96P20 1/20 0.56
MAOB P27338 2/20 0.52
ALDH1A1 P00352 3/20 0.48
HSD17B10 Q99714 1/20 0.48
MAOA P21397 2/20 0.47
GSTP1 P09211 1/20 0.44
LTA4H P09960 1/20 0.41
TSHR P16473 1/20 0.41
NCOA1 Q15788 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
MITF O75030 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
GFER P55789 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NLRP1 Q9C000 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2087211 0.82 ALDH1A1 (0.57) MEN1KMT2ANPC1RAB9ANLRP3
SCHEMBL3785169 0.82 MEN1 (0.63) MEN1KMT2ANPC1RAB9ANLRP3
SCHEMBL3789559 0.81 ABL1 (0.53) MEN1KMT2ANPC1RAB9AALDH1A1
SCHEMBL398444 0.80 ALDH1A1 (0.64) MEN1KMT2ANPC1RAB9ANLRP3
SCHEMBL1718820 0.79 MEN1 (0.83) MEN1KMT2ANPC1RAB9ANLRP3
SCHEMBL7804603 0.79 MEN1 (0.76) MEN1KMT2ANPC1RAB9ANLRP3
SCHEMBL3786362 0.79 MEN1 (0.70) MEN1KMT2ANPC1RAB9ANLRP3
SCHEMBL1271676 0.78 ALDH1A1 (0.56) MEN1KMT2AMAOBALDH1A1HSD17B10
SCHEMBL3785708 0.78 MAOB (0.55) MEN1KMT2ARAB9AMAOBALDH1A1
SCHEMBL3781262 0.77 MAOB (0.69) MEN1KMT2ANPC1RAB9ANLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MEN1 174/4885KMT2A 1474/4885NPC1 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.